By Gilang Cahya 
In a groundbreaking development that sheds new light on a perplexing modern medical mystery, an international consortium of researchers, spearheaded by the University of California San Diego (UC San Diego), has pinpointed a potent microbial culprit behind the significant increase in early-onset colorectal cancer: a bacterial toxin known as colibactin. This discovery, published in the esteemed scientific journal Nature, offers a compelling explanation for why individuals are developing this aggressive form of cancer at increasingly younger ages, often before the age of 50.
Colibactin is a harmful substance produced by specific strains of Escherichia coli (E. coli) bacteria that commonly inhabit the human colon and rectum. Its notoriety stems from its remarkable ability to directly damage and alter DNA. The new research meticulously details how early-life exposure to this bacterial toxin can leave a distinct and enduring genetic signature on the DNA of colon cells. This signature, the scientists propose, significantly elevates the risk of developing colorectal cancer in individuals who were exposed during their formative years.
A Global Genetic Detective Story
The comprehensive study analyzed an impressive 981 colorectal cancer genomes. These samples were drawn from patients across 11 countries, encompassing both individuals diagnosed with early-onset disease (typically defined as diagnosis before age 50) and those with late-onset disease (diagnosed after age 70). The research team employed sophisticated genomic analysis to meticulously identify specific patterns of DNA mutations.
A striking finding emerged: these colibactin-induced mutation patterns were a staggering 3.3 times more prevalent in early-onset cases, particularly in adults under the age of 40, when compared to their counterparts diagnosed much later in life. Furthermore, the geographical distribution of these mutation patterns closely mirrored countries that exhibit a high incidence of early-onset colorectal cancer, suggesting a direct link between the presence of colibactin-producing bacteria and the escalating rates of this disease in younger populations globally.
The Genome as a Historical Record
"These mutation patterns are a kind of historical record in the genome, and they point to early-life exposure to colibactin as a driving force behind early-onset disease," explained Ludmil Alexandrov, the study’s senior author and a distinguished professor in the Shu Chien-Gene Lay Department of Bioengineering and the Department of Cellular and Molecular Medicine at UC San Diego. Professor Alexandrov, who is also affiliated with the UC San Diego Moores Cancer Center and serves as the Deputy Director of the Sanford Stem Cell Fitness and Space Medicine Center, emphasized the profound implications of these genetic imprints.
While previous research, including earlier investigations from Professor Alexandrov’s laboratory, had identified colibactin-related mutations in approximately 10 to 15 percent of all colorectal cancer cases, these studies either focused predominantly on late-onset disease or did not make a clear distinction between early- and late-onset diagnoses. This latest study marks a pivotal moment, being the first to definitively demonstrate a substantial enrichment of colibactin-related mutations specifically within the cohort of early-onset colorectal cancer patients.
A Growing Public Health Crisis
The implications of these findings are far-reaching and concerning. Colorectal cancer, once predominantly considered a disease affecting older adults, has witnessed an alarming surge in incidence among young people. This trend is not isolated to a single region; it has been observed in at least 27 countries worldwide. The statistics are stark: the incidence of colorectal cancer in adults under the age of 50 has roughly doubled every decade for the past 20 years. Projections indicate that if current trends persist, colorectal cancer is poised to become the leading cause of cancer-related death among young adults by the year 2030, a chilling prospect that underscores the urgency of this research.
The Mystery of the Missing Link
For years, the underlying reasons for this escalating crisis have remained largely unknown. Young adults diagnosed with colorectal cancer often present without a family history of the disease and typically have few of the traditionally recognized risk factors such as obesity, hypertension, or a history of polyps. This lack of clear identifiable causes has fueled intense speculation about the role of potential hidden environmental or microbial exposures – a realm that this new study directly and effectively investigates.
Serendipity in Scientific Discovery
The genesis of this pivotal study was not initially centered on early-onset colorectal cancer. "When we started this project, we weren’t planning to focus on early-onset colorectal cancer," admitted study co-first author Marcos Díaz-Gay, who was a postdoctoral researcher in Alexandrov’s lab at the time. "Our original goal was to examine global patterns of colorectal cancer to understand why some countries have much higher rates than others. But as we dug into the data, one of the most interesting and striking findings was how frequently colibactin-related mutations appeared in the early-onset cases." This unexpected observation redirected the team’s focus, leading to a profound discovery.
Early Colonization, Late Consequences
The research meticulously details how colibactin’s damaging effects appear to commence at a remarkably early stage in life. By employing molecular techniques to date the origin of each identified mutational signature, the scientists have demonstrated that colibactin-associated mutations emerge early in the process of tumor development. This aligns with prior research suggesting that these specific mutations can occur within the first decade of a person’s life.
Furthermore, the study reveals that colibactin-related mutations account for approximately 15% of what are known as "APC driver mutations." These are critical early genetic alterations that play a direct and significant role in initiating and promoting cancer development. In essence, the presence of colibactin can accelerate the timeline of cancer initiation.
"If someone acquires one of these driver mutations by the time they’re 10 years old," Professor Alexandrov elaborated, "they could be decades ahead of schedule for developing colorectal cancer, getting it at age 40 instead of 60." This implies that colibactin-producing bacteria may silently colonize children’s colons, instigating molecular changes in their DNA that lay the groundwork for colorectal cancer years, or even decades, before any outward symptoms manifest.
While the findings provide robust support for this hypothesis, Professor Alexandrov prudently cautioned that further rigorous research is essential to definitively establish causality.
Building on a Foundation of Genomic Insights
This significant contribution is part of a larger, ongoing effort by the Cancer Grand Challenges team Mutographs, a collaborative initiative funded by Cancer Research UK. It represents the latest milestone in a burgeoning body of research advanced by Professor Alexandrov, Dr. Díaz-Gay, and their colleagues over several years. Their collective expertise lies in deciphering the complex patterns of DNA mutations that arise from various environmental exposures – including ultraviolet (UV) radiation and bacterial toxins – as well as lifestyle choices such as smoking and alcohol consumption. Each of these factors leaves a distinct genetic fingerprint, a unique mutational signature that serves as a crucial clue in pinpointing the origins of different types of cancer.
This latest breakthrough on colorectal cancer builds upon a long-term collaboration involving UC San Diego, the International Agency for Research on Cancer (IARC) in France, and the Wellcome Sanger Institute in the UK. This partnership, facilitated by Cancer Grand Challenges funding, has already yielded critical insights into the mutational processes underlying esophageal, kidney, and head and neck cancers across the globe. The systematic cataloging of these mutational patterns across thousands of cancer genomes has been instrumental in identifying novel causes of cancer that had previously evaded detection.
"Not every environmental factor or behavior we study leaves a mark on our genome," Professor Alexandrov noted. "But we’ve found that colibactin is one of those that can. In this case, its genetic imprint appears to be strongly associated with colorectal cancers in young adults."
Unanswered Questions and Future Directions
The team’s groundbreaking discovery opens a Pandora’s Box of new questions that demand urgent investigation. How exactly are children exposed to colibactin-producing bacteria? What preventative measures can be implemented to mitigate this exposure? Are specific environmental factors, dietary habits, or lifestyle choices more conducive to the proliferation of colibactin-producing bacteria? And crucially, how can individuals ascertain if they have already acquired these cancer-predisposing mutations?
The research team is actively pursuing several hypotheses. They are conducting further in-depth examinations of the correlation between colibactin and the risk of early-onset colorectal cancer. Additionally, they are exploring the potential therapeutic role of probiotics in safely eliminating harmful bacterial strains from the gut. A significant area of development includes the creation of early detection tests that analyze stool samples for the presence of colibactin-related mutations, offering a non-invasive method for risk assessment.
Regional Variations and the Promise of Targeted Prevention
In parallel with their focus on colibactin, the team continues its global pursuit of identifying other cancer-linked mutational signatures. The recent Nature study also revealed an increase in specific mutational signatures in colorectal cancers originating from certain countries, including Argentina, Brazil, Colombia, Russia, and Thailand. This suggests that localized environmental exposures may also contribute significantly to cancer risk in these regions.
"It’s possible that different countries have different unknown causes," observed Dr. Díaz-Gay, who is now leading a new phase of this research at his newly established laboratory at the Spanish National Cancer Research Center (CNIO) in Madrid, Spain. "That could open up the potential for targeted, region-specific prevention strategies." This insight holds the promise of developing highly localized and effective public health interventions.
A Paradigm Shift in Cancer Understanding
Professor Alexandrov highlighted a broader, transformative implication of this research: the potential for many cancers to originate from environmental or microbial exposures that occur in early life, long before any clinical diagnosis can be made.
"This reshapes how we think about cancer," he concluded. "It might not be just about what happens in adulthood – cancer could potentially be influenced by events in early life, perhaps even the first few years. Sustained investment in this type of research will be critical in the global effort to prevent and treat cancer before it’s too late." This perspective marks a significant departure from traditional views of cancer development, emphasizing the critical, often overlooked, role of early life exposures in shaping long-term health trajectories. The findings underscore the importance of a holistic, lifelong approach to cancer prevention and research, recognizing that the roots of disease may be sown much earlier than previously understood.
